Update History 2024-01-29 19:21:34
Photobiomodulation majorpublished
Photobiomodulation
Photobiomodulation (PBM), formerly known as Low-Level Laser Therapy (LLLT), is a non-invasive therapeutic technique involving the application of light, typically in the red to near-infrared (NIR) spectrum, to promote tissue repair, reduce inflammation and pain, and provide various other therapeutic effects. This technique has gained significant attention in clinical and research settings due to its […]
Page Snapshot
Microbiome-targeted interventions (MBTIs) are validated using a dual-evidence logical framework. First, the intervention must realign the condition’s microbiome signature by increasing beneficial taxa that are consistently depleted and reducing pathogenic taxa that are consistently enriched. Second, the intervention must demonstrate measurable clinical benefit. Concordance of these effects in the same context validates the intervention as an MBTI and supports the clinical relevance of the microbiome signature.
- References
- Identified MMAs
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass
Photobiomodulation (PBM), formerly known as Low-Level Laser Therapy (LLLT), is a non-invasive therapeutic technique involving the application of light, typically in the red to near-infrared (NIR) spectrum, to promote tissue repair, reduce inflammation and pain, and provide various other therapeutic effects. This technique has gained significant attention in clinical and research settings due to its broad applications in wound healing, neurology, pain management, and musculoskeletal disorders.
Mechanisms of Action: The primary mechanism of action in PBM is believed to be the absorption of light by cytochrome c oxidase (CCO), a key component of the mitochondrial electron transport chain. Absorption of specific wavelengths of light (typically around 600-1000 nm) by CCO increases mitochondrial activity, resulting in enhanced production of adenosine triphosphate (ATP), the cellular energy currency. This process also modulates reactive oxygen species (ROS) production, which can affect various cell signaling pathways (Hamblin, 2017) [x].
Additionally, PBM has been shown to induce a transient increase in intracellular calcium concentration, which can activate various cellular signaling cascades, leading to changes in gene expression. These changes in gene expression are associated with increased cell proliferation and migration, angiogenesis, and changes in cytokine and growth factor production, thereby promoting tissue repair and reducing inflammation [x].
Therapeutic Applications:
| Application | Effect | References |
|---|---|---|
| Wound Healing | Accelerates wound healing | de Freitas & Hamblin, 2016 [x] |
| Enhances angiogenesis | ||
| Promotes collagen synthesis | ||
| Increases fibroblast proliferation | ||
| Reduces inflammation | ||
| Alleviates pain at the wound site | ||
| Pain Management | Reduces chronic and acute pain | Bjordal et al., 2003 [x] |
| Effective for musculoskeletal pain | ||
| Effective for neuropathic pain | ||
| Effective for post-surgical pain | ||
| Analgesic effect due to reduced inflammation and modulation of pain mediators | ||
| Neurological Applications | Potential in neurodegenerative diseases | Salehpour et al., 2018 [x] |
| Offers neuroprotection | ||
| Reduces neuroinflammation | ||
| Enhances neurogenesis | ||
| Musculoskeletal Disorders | Treats tendinitis | Alves et al., 2014 [x] |
| Treats arthritis | ||
| Treats muscle injuries | ||
| Reduces inflammation | ||
| Promotes tissue repair | ||
| Relieves pain |
Safety and Dosage: One of the advantages of PBM is its safety profile. When used correctly, PBM has minimal side effects. However, the therapeutic window is narrow, and the light dose (wavelength, intensity, duration, and treatment frequency) is critical. The Arndt-Schulz law in phototherapy suggests that low light doses have a stimulatory effect, while high doses can have an inhibitory effect. Therefore, appropriate dosing is crucial for effective treatment (Huang et al., 2009) [x].
Current Challenges and Future Directions: While a growing body of research supports the efficacy of PBM in various applications, there are still challenges to its widespread acceptance. These include variability in treatment protocols, lack of standardization in devices and dosimetry, and a need for more large-scale clinical trials. Future research is expected to focus on optimizing treatment parameters, understanding the mechanisms of action in more detail, and exploring new therapeutic applications.
Conclusion: Photobiomodulation represents a promising, non-invasive therapeutic approach with many applications. Its mechanisms of action, primarily through the modulation of mitochondrial activity and subsequent cellular responses, underpin its effectiveness in tissue repair, pain reduction, and anti-inflammatory effects. As research evolves, PBM will likely become an increasingly important tool in various medical fields.